Questions 81–90

  • Yousaf Ali


This chapter illustrates a variety of different scenarios of rheumatic disease in succinct question and answer format. It contains ten complex cases with potentially unusual diagnoses designed to stimulate thought and further reading in this rapidly evolving specialty.


Assessment of rheumatic diseases Complex rheumatology cases Rare rheumatic diseases Rheumatology board exam preparation Rheumatology case studies Study guide for rheumatology 


  1. 1.
    Efthimiou P, Georgy S. Pathogenesis and management of adult-onset Still’s disease. Semin Arthritis Rheum. 2006;36(3):144–52.CrossRefPubMedGoogle Scholar
  2. 2.
    Zandman-Goddard G, Shoenfeld Y. Ferritin in autoimmune diseases. Autoimmun Rev. 2007;6(7):457–63.CrossRefPubMedGoogle Scholar
  3. 3.
    Butteriss DJ, Clarke L, Dayan M, Birchall D. Use of colour duplex ultrasound to diagnose giant cell arteritis in a case of visual loss of uncertain aetiology. Br J Radiol. 2004;77(919):607–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Lazaridis C, Torabi A, Cannon S. Bilateral third nerve palsy and temporal arteritis. Arch Neurol. 2005;62(11):1766–8. ReviewCrossRefPubMedGoogle Scholar
  5. 5.
    Pless M, Rizzo JF III, Lamkin JC, Lessell S. Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol. 2000;20(3):216–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347(4):261–71. ReviewCrossRefPubMedGoogle Scholar
  7. 7.
    Seo P, Stone JH. Large-vessel vasculitis. Arthritis Rheum. 2004;51(1):128–39. ReviewCrossRefPubMedGoogle Scholar
  8. 8.
    Keith MP, Gilliland WR. Updates in the management of gout. Am J Med. 2007;120(3):221–4. ReviewCrossRefPubMedGoogle Scholar
  9. 9.
    Emmerson BT, Nagel SL, Duffy DL, Martin NG. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis. 1992;51:375.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Lesch M, Nyhan WL. A familial disorder of uric acidmetabolism and central nervous system function. Am J Med. 1964;36:561.CrossRefPubMedGoogle Scholar
  11. 11.
    Butt AA, Michaels S, Kissinger P. The association of serum lactate dehydrogenase level with selected opportunistic infections and HIV progression. Int J Infect Dis. 2002;6(3):178–81.CrossRefPubMedGoogle Scholar
  12. 12.
    Kaur N, Mahl TC. Pneumocystisjiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci. 2007;52(6):1481–4.CrossRefPubMedGoogle Scholar
  13. 13.
    Mutlu GM, Mutlu EA, Bellmeyer A, Rubinstein I. Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy. Am J Med. 2006;119(8):639–46. ReviewCrossRefPubMedGoogle Scholar
  14. 14.
    Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet. 2006;368(9533):404–18. ReviewCrossRefPubMedGoogle Scholar
  15. 15.
    Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004;117(1):39–50. ReviewCrossRefPubMedGoogle Scholar
  16. 16.
    Padovan M, Castellino G, Govoni M, Trotta F. The treatment of the rheumatological manifestations of the inflammatory bowel diseases. Rheumatol Int. 2006;26(11):953–8. ReviewCrossRefPubMedGoogle Scholar
  17. 17.
    Van den Bosch F, Kruithof E, De Vos M, De Keyser F, Mielants H. Crohn’s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet. 2000;356(9244):1821–2.CrossRefPubMedGoogle Scholar
  18. 18.
    Peluso R, Manguso F, Vitiello M, Iervolino S, Di Minno MND. Management of arthropathy in inflammatory bowel diseases. Therapeutic Advances in Chronic Disease. 2015;6(2):65-77. doi:10.1177/2040622314563929.CrossRefGoogle Scholar
  19. 19.
    Grosflam J, Weinblatt ME. Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity. Curr Opin Rheumatol. 1991;3(3):363–8. ReviewCrossRefPubMedGoogle Scholar
  20. 20.
    Takatori R, Takahashi KA, Tokunaga D, Hojo T, Fujioka M, Asano T, Hirata T, Kawahito Y, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo T. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. Clin Exp Rheumatol. 2006;24(5):546–54.PubMedGoogle Scholar
  21. 21.
    Miller PD, Bilezikian JP, Deal C, et al. Clinical use of teriperatide in the real world: initial insights. Endocr Pract. 2004;10:139.CrossRefPubMedGoogle Scholar
  22. 22.
    Erickson VR, Hwang PH. Wegener’s granulomatosis: current trends in diagnosis and management. Curr Opin Otolaryngol Head Neck Surg. 2007;15(3):170–6. ReviewCrossRefPubMedGoogle Scholar
  23. 23.
    Foster WP, Greene JS, Millman B. Wegener’s granulomatosis presenting as ophthalmoplegia and optic neuropathy. Otolaryngol Head Neck Surg. 1995;112(6):758–62.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Yousaf Ali
    • 1
  1. 1.Mount Sinai HospitalNew YorkUSA

Personalised recommendations